Imaging Everyone

NeuroLF is an ultra-compact brain Positron Emission Tomography system.
Our technology offers precision medicine and makes functional imaging accessible for people worldwide.

more

The Innovation

NeuroLF System

Meet the ultra-compact yet powerful brain Positron Emission Tomography (PET) device. NeuroLF offers functional brain imaging to everyone at a fraction of today’s cost.

more

Functional Images of the Brain

Starting with dementia diagnostic in general and Alzheimer’s disease in particular, our technology is applicable for the diagnosis of numerous brain related disorders.

more

The Team

Get to know us

We are a dedicated team consisting of mechanical, electrical and software engineers, paired with experienced scientifically and commercially minded team members.

more

Schedule a demo

We are looking forward to showing you our technology either virtually or on site.

Get in Touch

News

read all

Positrigo closes Financing Round and appoints new Board Members

June 10, 2025 Positrigo closes Financing Round and appoints new Board Members.

Positrigo appoints Qualimedis as Distributor in France

May 26, 2025 Qualimedis to become Positrigo’s distributor in France

Positrigo wins iF Design Award 2025

March 3, 2025 Positrigo wins iF DESIGN AWARD 2025 – an outstanding success in international design

2024 – A Year of Milestones

December 30, 2024 Positrigo looks back on a successful year with numerous achieved milestones

Positrigo Secures CE Mark in Europe for its Pioneering Dedicated Brain PET System

October 2, 2024 Positrigo secures CE Mark in Europe for NeuroLF System

Positrigo Receives FDA Clearance for Breakthrough Brain PET System

July 16, 2024 NeuroLF now FDA cleared and available for sale in the US.

NeuroLF brain images presented first time

April 4, 2024 First brain images from the NeuroLF system were presented at the ECCN conference.

Positrigo opens US subsidiary to benefit from promising market developments

October 16, 2023 Positrigo opens US subsidiary to benefit from promising market developments

Positrigo presents NeuroLF first time

September 13, 2023 Unveiling of NeuroLF System at EANM 2023 in Vienna

Preliminary Performance Data of NeuroLF – Prof. Simon Cherry new Advisory Board Member

June 8, 2023 Positrigo appoints Prof. Simon Cherry as Advisory Board member and reports preliminary performance data of NeuroLF

Positrigo receives Swiss Accelerator grant

May 3, 2023 Positrigo receives Swiss Accelerator grant from Innosuisse

2022 Review

December 29, 2022 Positrigo reflects on a successful Year.

Proof-of-Concept Publication in Journal of Imaging

December 21, 2022 Positrigo team co-authors proof-of-concept study

Positrigo closes successfully Series B Funding Round.

October 24, 2022 Positrigo receives CHF 5.5 million in Series B funding round.

Positrigo among TOP 100 Swiss Startups

September 8, 2022 Positrigo has been listed as TOP 100 Swiss Startup.

Positrigo receives Innosuisse certificate

August 11, 2022 “The Positrigo team has done an excellent job in recent years” – Michael Stucky, Innosuisse Coach

Interview with Positrigo Founders in Insightcare Magazine

July 25, 2022 Positrigo was featured in the Insightcare Magazine. Read the interview with two Positrigo founders.

Positrigo supports functional imaging research

June 20, 2022 In a recent research article Positrigo’s dedicated brain PET prototype device was used for the “Evaluation of STIR Library Adapted for PET Scanners with Non-Cylindrical Geometry”.

Focus on dedicated brain PET systems at ECCN 2022

March 17, 2022 Experts agree that the need for dedicated brain PET systems increases significantly if disease-modifying therapies or disease-preventing drugs for Alzheimer’s disease become available.

Positrigo among top 50 of the W.A. de Vigier Foundation

January 25, 2022 Positrigo is among the top 50 companies competing for the W.A. de Vigier Foundation Award 2022.

Positrigo selected for IMD Startup Competition 2021/2022

December 17, 2021 Positrigo is among 37 companies which have been selected to participate in the 2021/2022 IMD Startup Competition

Positrigo and Bottneuro sign collaboration agreement

November 2, 2021 The two Swiss based companies Positrigo and Bottneuro have announced a cooperation

Positrigo certified for ISO13485:2016

September 27, 2021 Positrigo demonstrates commitment to provide medical devices and related services…

Visit by Minister President of Saxony

September 10, 2021 Last week Michael Kretschmer who serves currently as the Minister President of Saxony (Germany) and a delegation visited us

Performance of the Ultra-Compact Fully Integrated Brain PET System BPET

September 1, 2021 Positrigo reports about preliminary performance data of the BPET device which serves as prototype for the NeuroLF® brain PET scanner.

Successful exploratory clinical study with ultracompact brain PET device

July 28, 2021 Positrigo reports completion of the ExploreBPET clinical study, using the novel investigational medical device BPET for imaging of the human brain.

Financial boost for Positrigo

July 15, 2021 Positrigo receives funding from the European Innovation Council (EIC Fund) for its breakthrough brain PET scanner technology.

Positrigo appoints VP Business Development and Marketing

June 3 2021 Positrigo appoints Dr. Stefan Bircher as new VP Business Development and Marketing.

Positrigo is expanding at Technopark Zurich

March 25, 2021 Positrigo is growing and is expanding its office space at Technopark Zurich.